Want to see YDES full AI Analyst Report?
YD Bio Limited (YDES) Financial Statements
YD Bio Limited Financial Overview
YD Bio Limited's market cap is currently $420.81M. The company's EPS TTM is $-0.99; its P/E ratio is -49.50; YD Bio Limited is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 596.82K | $ 510.36K | $ 350.13K | $ 0.00 | $ 0.00 |
| Gross Profit | $ -42.15K | $ 155.36K | $ 153.44K | $ 0.00 | $ 0.00 |
| Operating Income | $ -5.27M | $ -1.46M | $ -9.85K | $ -2.32M | $ -1.72M |
| EBITDA | $ -8.10M | $ -1.28M | $ 22.25K | $ 3.79M | $ 8.70M |
| Net Income | $ -8.31M | $ -1.41M | $ 13.56K | $ 3.79M | $ 8.70M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 6.01M | $ 3.13M | $ 87.10K | $ 14.13K | $ 5.40K |
| Total Assets | $ 13.78M | $ 6.86M | $ 321.21K | $ 17.93M | $ 118.06M |
| Total Debt | $ 6.76K | $ 22.55K | $ 47.58K | $ 0.00 | $ 0.00 |
| Net Debt | $ -6.00M | $ -3.11M | $ -39.52K | $ -14.13K | $ -5.40K |
| Total Liabilities | $ 16.64M | $ 273.98K | $ 298.22K | $ 6.74M | $ 9.11M |
| Stockholders' Equity | $ -2.86M | $ 6.59M | $ 22.99K | $ 11.20M | $ 108.96M |
| Cash Flow | |||||
| Free Cash Flow | $ -8.04M | $ -4.75M | $ -55.95K | $ -3.02M | $ -688.42K |
| Operating Cash Flow | $ -6.60M | $ -1.84M | $ -55.66K | $ -3.02M | $ -688.41K |
| Investing Cash Flow | $ -1.44M | $ -2.90M | $ -290.00 | $ 100.38M | $ -1.15M |
| Financing Cash Flow | $ 10.87M | $ 7.73M | $ 113.89K | $ -97.34M | $ 1.15M |
Currency in USD